Frontlight ResearchEarly access
Heart failure trials in United Kingdom
59 of 95 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- London, Newcastle upon Tyne
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Barnet, Bristol, Exeter, Halifax, High Wycombe, London, Oldham, Sheffield, Truro, York
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bristol, Clydebank, Exeter, Halifax, Harrow, London
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - No phaseTaking peopleEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
- Where
- Leeds, London
- Age
- 40 years and over
- People
- 50 worldwide
- Run by
- Axon Therapies, Inc.
See details and how to joinNCT07403058 - Phase 3Taking peopleStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Where
- Basingstoke, Cottingham, Dudley, Dundonald, Glasgow, Harefield, Southampton, Swindon
- Age
- 18 years to 85 years
- People
- 1,800 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00 - No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Leeds, London, Manchester
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Airdrie, Ashington, Belfast, Bournemouth, Bridgend, Bristol, Chichester, Dundee, Exeter, Glasgow, Great Cambourne, High Wycombe, Inverness, Kilmarnock, Leicester, London, Manchester, Newcastle upon Tyne, Portadown, Craigavon, Sandbach, Stockton-on-Tees, Thetford, Wakefield, West Kirby
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Belfast, Bristol, Glasgow, Leeds, Leicester, Liverpool, Newcastle upon Tyne
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Belfast, Chichester, Dundee, High Wycombe, London, Norwich, Sheffield
- Age
- 18 years to 79 years
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Aberdeen, Chesterfield, Dundee, Gatley, Glasgow, London, Norwich, Penzance, Redruth, Sandbach, Southampton, Swansea, Weston-super-Mare, Wolverhampton, Woodbridge, Yate
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Bellshill, Birmingham, Cardiff, Liverpool, London, Manchester
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Belfast, Bristol, Glasgow, Leeds, Leicester, Liverpool, Newcastle upon Tyne
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 2Taking peopleDose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- London
- Age
- 18 years to 80 years
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Airdrie, Barnet, Cambridge, Clydebank, Exeter, Harefield, Hastings, High Wycombe, Kent, Kings Lynn, Lincoln, London, Middlesbrough, Portsmouth, Sheffield, Sunderland, Wakefield
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Birmingham, High Wycombe, London, Middlesbrough, Southampton
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - No phaseNot yet taking people in United KingdomEffectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
- Where
- Leicester
- Age
- 18 years and over
- People
- 80
- Run by
- University of Leicester
See details and how to joinNCT07500948 - No phaseNot yet taking people in United KingdomRemote Monitoring and Optimization of Heart Failure Therapy
- Where
- Southampton
- Age
- 18 years to 85 years
- People
- 800 worldwide
- Run by
- Zoll Medical Corporation
See details and how to joinNCT07622472 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Ashton-under-Lyne, Basildon, Belfast, Birmingham, Brighton, Bristol, Cardiff, Clydebank, Dundee, Glasgow, Kings Lynn, Leeds, London, Sandbach, Southampton, Woodbridge
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 4Taking peopleAcalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
- Where
- Bournemouth, Oxford, Plymouth, Romford, Stockton, Sutton Coldfield
- Age
- 18 years to 130 years
- People
- 60 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06651970 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Ashford, Ashington, Brighton, Cardiff, Chester, Darlington, Dudley, Durham, Glasgow, Leeds, Liverpool, London, Manchester, Plymouth, Portadown, Southampton, Swindon
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- Where
- Bournemouth, Bristol, Glasgow, London
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06024746 - Phase 1Taking peopleA Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
- Where
- London
- Age
- 40 years to 75 years
- People
- 36
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07218627 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Airdrie, Barnet, Belfast, Bridgend, Bristol, Chesterfield, Chichester, Coventry, Craigavon, Dorchester, Dundee, Eastbourne, Harrow, Inverness, Isleworth, Kirkcaldy, Leicester, Lincoln, Liverpool, London, Middlesbrough, Newcastle upon Tyne, North Shields, Norwich, Nuneaton, Oldham, Plymouth, Rhyl, Stevenage, Sunderland, Taunton, Tooting, Torquay, Truro, Wakefield, Worcester
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleMonitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
- Where
- Ashford, Aylesbury, Belfast, Bridgend, Croydon, Glasgow, Hardwick, Hull, Lincoln, London, Manchester, Milton Keynes, Nottingham, Patrington, Plymouth, Pont-y-clun, Walsall, Welwyn Garden City
- Age
- 18 years and over
- People
- 300
- Run by
- Heartfelt Technologies
See details and how to joinNCT07067658 - No phaseNot yet taking people in United KingdomEarly Detection and IntervenTion in Heart Failure
- Where
- Edinburgh
- Age
- 65 years and over
- People
- 18,000 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07731490